Program details and terms and conditions
 
Program details:
Terms and Conditions for Bridge to Commercial Coverage Offer (“Bridge Offer”): Aimovig® free for up to 12 doses over 24 months (whichever occurs first) from the first prescription filled under the Bridge Offer. Available if patient has a prescription, is commercially insured, and 18 years or older. This offer is not valid if patient is uninsured or receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, the Retiree Drug Subsidy Program, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE or where prohibited by law. Cash Discount Cards and other noninsurance plans are not valid as primary under this offer. If at any time patient begins receiving coverage under any such federal-, state-, or governmentfunded healthcare program, patient will no longer be able to use this offer and patient must call 833-AIMOVIG to stop participation. By participating in this offer, patient acknowledges intent to pursue insurance coverage for Aimovig® with their healthcare provider. Ongoing eligibility requires that patient has a prior authorization or medical exception denied within 90 days of first use of offer. Once insurance approval is obtained, patient is no longer eligible for this offer. No purchase necessary. This is not health insurance.Participation is not a guarantee of insurance coverage. This offer is not renewable. Valid in the United States, Puerto Rico, and the US territories. Other restrictions may apply. This offer is subject to change or discontinuation without notice.
Terms and Conditions for Copay Offer: Pay a $5 copay per month, up to a maximum benefit of $3500 annually. Available if patient has a prescription, is commercially insured, and 18 years or older. This offer is not valid if patient is uninsured or receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, the Retiree Drug Subsidy Program, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE or where prohibited by law. Cash Discount Cards and other noninsurance plans are not valid as primary under this offer. If at any time patient begins receiving coverage under any such federal-, state-, or government-funded healthcare program, patient will no longer be able to use this offer and patient must call 833-AIMOVIG to stop participation. Patient may not seek reimbursement for value received from this offer from any third-party payers, including flexible spending accounts or healthcare savings accounts.This is not health insurance. Participation is not a guarantee of insurance coverage. Valid in the United States, Puerto Rico, and the US territories. Other restrictions may apply. This offer is subject to change or discontinuation without notice. If you become aware that your health plan or pharmacy benefit manager does not allow the use of manufacturer copay support as part of your health plan design, you agree to comply with your obligations, if any, to disclose your use of the card to your insurer. This offer is ongoing and in order to remain eligible, patient must re-enroll every 12 months by visiting www.aimovigaccesscard.com/ or by calling 833-AIMOVIG (833-246-6844).

Back


For more information about Aimovig® please visit: aimovig.com  | Privacy Policy  | Terms of Use

For more information about Aimovig please visit:   aimovig.com  | Privacy Policy  | Terms of Use

+

Important Safety Information

Who should not use Aimovig®?

Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®.

Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig®?

Aimovig® may cause serious side effects, including:

  • Allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.
  • Constipation with serious complications. Severe constipation can happen after receiving Aimovig®. In some cases people have been hospitalized or needed surgery. Contact your HCP if you have severe constipation.

The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation.

These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for Full Prescribing Information and Patient Product Information.

Approved Use

Aimovig® (erenumab-aooe) is a prescription medicine used for the preventive treatment of migraine in adults.

  

© 2019 Amgen Inc. All rights reserved.

Amgen Inc.
One Amgen Center Drive, Thousand Oaks, CA 91320-1799

Novartis Pharmaceuticals Corp.
One Health Plaza, East Hanover, NJ 07936-1080                                                   




© 2019 Amgen Inc. All rights reserved.

Amgen Inc. One Amgen Center Drive,Thousand Oaks, CA 91320-1799

Novartis Pharmaceuticals Corp.
One Health Plaza, East Hanover, NJ 07936-1080